Dimitriou F - Search Results

1

Nature and management of melanoma recurrences following adjuvant anti-PD-1 based therapy.

Woodford R, McKeown J, Hoeijmakers LL, Mangana J, Dimitriou F, Allayous C, Zaman F, Aya F, Marsiglio J, Goodman R, Rayson V, Placzke J, Kessels J, Ramalyte E, Haque W, Wilson I, Trojaniello C, Benannoune N, Roberts-Thomson R, Robert C, Blank CU, Dummer R, Lebbe C, Haydon A, Arance A, Hu-Lieskovan S, Johnson DB, Mcarthur GA, Rutkowski P, Neyns B, Sullivan RJ, Weber J, Carlino MS, Ascierto PA, Lo S, Long GV, Menzies AM. Woodford R, et al. Among authors: dimitriou f. Eur J Cancer. 2024 Nov;212:115055. doi: 10.1016/j.ejca.2024.115055. Epub 2024 Sep 29. Eur J Cancer. 2024. PMID: 39366209

2

Sensitivity and specificity of T-cell receptor PCR BIOMED-2 clonality analysis for the diagnosis of cutaneous T-cell lymphoma.

Moczko A, Dimitriou F, Kresbach H, Amarov B, Hoetzenecker W, Pascolo S, Anzengruber F, Koch T, Duda A, Guenova E. Moczko A, et al. Among authors: dimitriou f. Eur J Dermatol. 2020 Feb 1;30(1):12-15. doi: 10.1684/ejd.2020.3698. Eur J Dermatol. 2020. PMID: 32250251

3

Enhancement of antibody-dependent cellular cytotoxicity is associated with treatment response to extracorporeal photopheresis in Sézary syndrome.

Iselin C, Chang YT, Schlaepfer T, Fassnacht C, Dimitriou F, Nägeli M, Pascolo S, Hoetzenecker W, Bobrowicz M, Guenova E. Iselin C, et al. Among authors: dimitriou f. Oncoimmunology. 2021 Jan 31;10(1):1873530. doi: 10.1080/2162402X.2021.1873530. Oncoimmunology. 2021. PMID: 33643690 Free PMC article.

4

Sarcoid-like reactions in patients receiving modern melanoma treatment.

Dimitriou F, Frauchiger AL, Urosevic-Maiwald M, Naegeli MC, Goldinger SM, Barysch M, Franzen D, Kamarachev J, Braun R, Dummer R, Mangana J. Dimitriou F, et al. Melanoma Res. 2018 Jun;28(3):230-236. doi: 10.1097/CMR.0000000000000437. Melanoma Res. 2018. PMID: 29485531 Free PMC article.

5

Cytokine Release Syndrome During Sequential Treatment With Immune Checkpoint Inhibitors and Kinase Inhibitors for Metastatic Melanoma.

Dimitriou F, Matter AV, Mangana J, Urosevic-Maiwald M, Micaletto S, Braun RP, French LE, Dummer R. Dimitriou F, et al. J Immunother. 2019 Jan;42(1):29-32. doi: 10.1097/CJI.0000000000000236. J Immunother. 2019. PMID: 29939877 Free article.

6

The World of Melanoma: Epidemiologic, Genetic, and Anatomic Differences of Melanoma Across the Globe.

Dimitriou F, Krattinger R, Ramelyte E, Barysch MJ, Micaletto S, Dummer R, Goldinger SM. Dimitriou F, et al. Curr Oncol Rep. 2018 Sep 24;20(11):87. doi: 10.1007/s11912-018-0732-8. Curr Oncol Rep. 2018. PMID: 30250984 Review.

7

Myositis and neuromuscular side-effects induced by immune checkpoint inhibitors.

Moreira A, Loquai C, Pföhler C, Kähler KC, Knauss S, Heppt MV, Gutzmer R, Dimitriou F, Meier F, Mitzel-Rink H, Schuler G, Terheyden P, Thoms KM, Türk M, Dummer R, Zimmer L, Schröder R, Heinzerling L. Moreira A, et al. Among authors: dimitriou f. Eur J Cancer. 2019 Jan;106:12-23. doi: 10.1016/j.ejca.2018.09.033. Epub 2018 Nov 17. Eur J Cancer. 2019. PMID: 30453170

8

Cytokine release syndrome as an important differential diagnosis of severe skin toxicity with organ damage during switch from immunotherapy to targeted therapy in metastatic melanoma.

Dimitriou F, Mangana J, Micaletto S, Braun RP, Dummer R. Dimitriou F, et al. Melanoma Res. 2019 Feb;29(1):107-108. doi: 10.1097/CMR.0000000000000544. Melanoma Res. 2019. PMID: 30557221 Free article. No abstract available.

9

Single-center real-life experience with low-dose ipilimumab monotherapy in adjuvant setting for patients with stage III melanoma.

Mangana J, Dimitriou F, Braun R, Ludwig S, Dummer R, Barysch MJ. Mangana J, et al. Among authors: dimitriou f. Melanoma Res. 2019 Dec;29(6):648-654. doi: 10.1097/CMR.0000000000000593. Melanoma Res. 2019. PMID: 30870270 Free article.

10

Melanoma patients with additional primary cancers: a single-center retrospective analysis.

Dimitriou F, Mangana J, Curioni-Fontecedro A, Rechsteiner M, Turko P, Braun RP, Dummer R, Cheng PF. Dimitriou F, et al. Oncotarget. 2019 May 21;10(36):3373-3384. doi: 10.18632/oncotarget.26931. eCollection 2019 May 21. Oncotarget. 2019. PMID: 31164959 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

63 results

Search Page

Filters